35 research outputs found

    Perspectives on climate information use in the Caribbean

    Get PDF
    Within research on climate information for decision-making, localized insights on the influences of climate information use remain limited in small and low-income countries. This paper offers an empirical contribution on Caribbean perspectives of climate information use considering current barriers and enablers in the region. We employ thematic analysis of 26 semi-structured interviews with region-focused sectoral experts (including end-users and decision-makers) drawn from climate adaptation, disaster risk reduction, and resilience focused initiatives and institutions. The results reaffirm presence of known barriers, such as the crucial role of finance, but notably we identify a range of interlinked enabling and catalyzing conditions necessary for the effective use of climate information. These conditions include the need for island- and sector- contextualized climate information, the role of international donors, the importance of adequate human resource capacity and presence of loud voices/climate champions, as well as the need for effective political and legislative mandates and for greater co-production. We construct a visualization of respondents' understanding of influencing factor interrelationships. This shows how their heuristics of climate information use for decision-making intricately link with roles for proactive climate champions, and that available finance often reflects donor interests. We end by discussing how these insights can contribute to strategies for more effective climate information use to promote resilience within the region

    Memory CD8<sup>+</sup> T cells exhibit tissue imprinting and non-stable exposure-dependent reactivation characteristics following blood-stage Plasmodium berghei ANKA infections

    Get PDF
    Experimental cerebral malaria (ECM) is a severe complication of Plasmodium berghei ANKA (PbA) infection in mice, characterized by CD8(+) T‐cell accumulation within the brain. Whilst the dynamics of CD8(+) T‐cell activation and migration during extant primary PbA infection have been extensively researched, the fate of the parasite‐specific CD8(+) T cells upon resolution of ECM is not understood. In this study, we show that memory OT‐I cells persist systemically within the spleen, lung and brain following recovery from ECM after primary PbA‐OVA infection. Whereas memory OT‐I cells within the spleen and lung exhibited canonical central memory (Tcm) and effector memory (Tem) phenotypes, respectively, memory OT‐I cells within the brain post‐PbA‐OVA infection displayed an enriched CD69(+)CD103(−) profile and expressed low levels of T‐bet. OT‐I cells within the brain were excluded from short‐term intravascular antibody labelling but were targeted effectively by longer‐term systemically administered antibodies. Thus, the memory OT‐I cells were extravascular within the brain post‐ECM but were potentially not resident memory cells. Importantly, whilst memory OT‐I cells exhibited strong reactivation during secondary PbA‐OVA infection, preventing activation of new primary effector T cells, they had dampened reactivation during a fourth PbA‐OVA infection. Overall, our results demonstrate that memory CD8(+) T cells are systemically distributed but exhibit a unique phenotype within the brain post‐ECM, and that their reactivation characteristics are shaped by infection history. Our results raise important questions regarding the role of distinct memory CD8(+) T‐cell populations within the brain and other tissues during repeat Plasmodium infections

    Exhausted CD4+ T Cells during Malaria Exhibit Reduced mTORc1 Activity Correlated with Loss of T-bet Expression

    Get PDF
    CD4&lt;sup&gt;+&lt;/sup&gt; T cell functional inhibition (exhaustion) is a hallmark of malaria and correlates with impaired parasite control and infection chronicity. However, the mechanisms of CD4&lt;sup&gt;+&lt;/sup&gt; T cell exhaustion are still poorly understood. In this study, we show that Ag-experienced (&lt;i&gt;Ag-exp&lt;/i&gt;) CD4&lt;sup&gt;+&lt;/sup&gt; T cell exhaustion during &lt;i&gt;Plasmodium yoelii&lt;/i&gt; nonlethal infection occurs alongside the reduction in mammalian target of rapamycin (mTOR) activity and restriction in CD4&lt;sup&gt;+&lt;/sup&gt; T cell glycolytic capacity. We demonstrate that the loss of glycolytic metabolism and mTOR activity within the exhausted &lt;i&gt;Ag-exp&lt;/i&gt;CD4&lt;sup&gt;+&lt;/sup&gt; T cell population during infection coincides with reduction in T-bet expression. T-bet was found to directly bind to and control the transcription of various mTOR and metabolism-related genes within effector CD4&lt;sup&gt;+&lt;/sup&gt; T cells. Consistent with this, &lt;i&gt;Ag-exp&lt;/i&gt;Th1 cells exhibited significantly higher and sustained mTOR activity than effector T-bet- (non-Th1) &lt;i&gt;Ag-exp&lt;/i&gt;T cells throughout the course of malaria. We identified mTOR to be redundant for sustaining T-bet expression in activated Th1 cells, whereas mTOR was necessary but not sufficient for maintaining IFN-&#x3B3; production by Th1 cells. Immunotherapy targeting PD-1, CTLA-4, and IL-27 blocked CD4&lt;sup&gt;+&lt;/sup&gt; T cell exhaustion during malaria infection and was associated with elevated T-bet expression and a concomitant increased CD4&lt;sup&gt;+&lt;/sup&gt; T cell glycolytic metabolism. Collectively, our data suggest that mTOR activity is linked to T-bet in &lt;i&gt;Ag-exp&lt;/i&gt;CD4&lt;sup&gt;+&lt;/sup&gt; T cells but that reduction in mTOR activity may not directly underpin &lt;i&gt;Ag-exp&lt;/i&gt;Th1 cell loss and exhaustion during malaria infection. These data have implications for therapeutic reactivation of exhausted CD4&lt;sup&gt;+&lt;/sup&gt; T cells during malaria infection and other chronic conditions

    Memory CD8 + T cells exhibit tissue imprinting and non‐stable exposure‐dependent reactivation characteristics following blood‐stage Plasmodium berghei ANKA infections

    Get PDF
    From Wiley via Jisc Publications RouterHistory: received 2020-11-02, rev-recd 2021-08-09, accepted 2021-08-13, pub-electronic 2021-08-27Article version: VoRPublication status: PublishedFunder: Medical Research Council; Id: http://dx.doi.org/10.13039/501100000265; Grant(s): G0900487, MR/R010099/1Abstract: Experimental cerebral malaria (ECM) is a severe complication of Plasmodium berghei ANKA (PbA) infection in mice, characterized by CD8+ T‐cell accumulation within the brain. Whilst the dynamics of CD8+ T‐cell activation and migration during extant primary PbA infection have been extensively researched, the fate of the parasite‐specific CD8+ T cells upon resolution of ECM is not understood. In this study, we show that memory OT‐I cells persist systemically within the spleen, lung and brain following recovery from ECM after primary PbA‐OVA infection. Whereas memory OT‐I cells within the spleen and lung exhibited canonical central memory (Tcm) and effector memory (Tem) phenotypes, respectively, memory OT‐I cells within the brain post‐PbA‐OVA infection displayed an enriched CD69+CD103− profile and expressed low levels of T‐bet. OT‐I cells within the brain were excluded from short‐term intravascular antibody labelling but were targeted effectively by longer‐term systemically administered antibodies. Thus, the memory OT‐I cells were extravascular within the brain post‐ECM but were potentially not resident memory cells. Importantly, whilst memory OT‐I cells exhibited strong reactivation during secondary PbA‐OVA infection, preventing activation of new primary effector T cells, they had dampened reactivation during a fourth PbA‐OVA infection. Overall, our results demonstrate that memory CD8+ T cells are systemically distributed but exhibit a unique phenotype within the brain post‐ECM, and that their reactivation characteristics are shaped by infection history. Our results raise important questions regarding the role of distinct memory CD8+ T‐cell populations within the brain and other tissues during repeat Plasmodium infections

    Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry

    Get PDF
    corecore